Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service

Coronavirus Disease 2019 Clinical Trial

— COVID-19  

Official title:

Comparison of General Characteristics of Patients Diagnosed COVID-19 Positive Followed In Service

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05092568
• Other study ID #: COVID-19
• Status: Recruiting
• Start date: May 5, 2022
• Est. completion date: July 15, 2022

Study information

• Verified date: May 2022
• Source: Saglik Bilimleri Universitesi
• Contact: Ozge MD Ozdemir, MD
• Phone: 9005326384089
• Email: drozgeozde[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

comparison of general characteristics of patients diagnosed COVID-19 positive followed In service

Description:

After the explanation about the study is made, informed consent form will be obtained from the pregnant women who were hospitalized in the pandemic gynecology service (D block 10th floor pandemic obstetrics service) due to COVID-19 and who agreed to participate in the study. In our study, the clinical status of pregnant patients with COVID-19 positive test results, who were followed up and treated in the pandemic service in Basaksehir City Hospital, will be obtained by asking the patient about the symptoms and vaccination status in the patient follow-up form prepared in advance. Laboratory findings and imaging results ( CT/ anteroposterior X-ray) will be obtained from the recorded data.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 45
• Est. completion date: July 15, 2022
• Est. primary completion date: July 15, 2022
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria: Pregnant patients positive COVID-19 test results followed up and treated in the pandemic service of Çam and Sakura City Hospital.

Exclusion Criteria: no exclusion criteria

-

Related Conditions & MeSH terms

• Coronavirus Disease 2019
• Coronavirus Infections
• COVID-19
• Symptoms and Signs
• Vaccinia

Locations

Country	Name	City	State
Turkey	Department of Obstetrics and Gynecology, Maternal-Fetal Medicine Unit, Basaksehir City Hospital, Hamidiye School of Medicine, University of Health Sciences,	Basaksehir	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Saglik Bilimleri Universitesi

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Participants	Number of Participants diagnosed of polymerase chain reaction assay Positive COVID-19 followed In service	Two months
Primary	Number of vaccinated participants	Vaccinated patients who were followed up in the service due to COVID-19	Two months
Primary	Number of non-vaccinated Participants	non-vaccinated patients who were followed up in the service due to COVID-19	Two months
Primary	rate of non-vaccinated -vaccinated Participants	rate of non-vaccinated- vaccinated Participants who were followed up in the service due to COVID-19	Two months
Primary	rate of covid symptoms	rate of covid common symptoms (cough, fever, shortness of breath ,sore throat ) in vaccinated and unvaccinated patients	Two months
Primary	rate of inflammatory parameters	rate of lymphocyte and albumin levels , C-reactive protein (CRP), D-dimer, Ferritin, lactate dehydrogenase(LDH), neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR) and C-reactive protein albumin ratio (CAR) levels in vaccinated and unvaccinated patients	Two months